MedTrace Logo

Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy

NCT03498417 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 135

Last updated 2018-07-30

No results posted yet for this study

Summary

The study is aimed at assessing IGF-1R-Abs in patients with Graves' disease, with or without GO, compared with healthy subjects and patients with autoimmune thyroiditis in a cross-sectional investigation.

Conditions

  • Graves Ophthalmopathy
  • Graves Disease
  • Autoimmune Thyroiditis

Interventions

DIAGNOSTIC_TEST

Serum antibodies against the IGF-1R

Measurement of antibodies against the IGF-1R in serum samples by ELISA

Sponsors & Collaborators

  • University of Pisa

    lead OTHER

Principal Investigators

  • Michele Marinò, MD · University of Pisa

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-20
Primary Completion
2018-07-20
Completion
2018-07-20

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03498417 on ClinicalTrials.gov